American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$706M |
| 2 |
Kenvue
KVUE
|
+$193M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 4 |
Entegris
ENTG
|
+$160M |
| 5 |
Merck
MRK
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$301M |
| 2 |
Visa
V
|
+$269M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$217M |
| 4 |
Allstate
ALL
|
+$172M |
| 5 |
Air Products & Chemicals
APD
|
+$163M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.13% |
| 2 | Financials | 13.26% |
| 3 | Healthcare | 12.32% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Zegna
ZGN
$3.75B
| $160K | ﹤0.01% |
10,943
-470
| -4% | -$6.07K |
|
2727
Coty
COTY
$2.42B
| $159K | ﹤0.01% |
13,332
+2,475
| +23% | +$30.2K |
|
2728
Trevi Therapeutics
TRVI
$2.62B
| $159K | ﹤0.01% |
46,206
+25,143
| +119% | +$56.1K |
|
2729
Pyxis Oncology
PYXS
$210M
| $159K | ﹤0.01% |
37,351
+23,580
| +171% | +$99.2K |
|
2730
Tilly's
TLYS
$123M
| $156K | ﹤0.01% |
22,967
+2,120
| +10% | +$15.5K |
|
2731
Acacia Research
ACTG
$452M
| $154K | ﹤0.01% |
28,875
+1,213
| +4% | +$5.06K |
|
|
HRT
2732
DELISTED
HireRight Holdings Corporation
HRT
| $154K | ﹤0.01% |
+10,772
| New | +$144K |
|
|
RPTX
2733
DELISTED
Repare Therapeutics
RPTX
| $153K | ﹤0.01% |
32,438
+6,107
| +23% | +$39.1K |
|
2734
SelectQuote
SLQT
$129M
| $153K | ﹤0.01% |
76,359
-1,106
| -1% | -$1.65K |
|
|
GTHX
2735
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $150K | ﹤0.01% |
34,648
+18,267
| +112% | +$63.7K |
|
2736
Star Holdings Shares of Beneficial Interest
STHO
$118M
| $150K | ﹤0.01% |
+11,575
| New | +$145K |
|
|
CONN
2737
DELISTED
Conn's Inc.
CONN
| $149K | ﹤0.01% |
44,609
-9,231
| -17% | -$39.5K |
|
2738
Actinium Pharmaceuticals
ATNM
$29.5M
| $148K | ﹤0.01% |
+18,852
| New | +$121K |
|
2739
Richardson Electronics
RELL
$299M
| $147K | ﹤0.01% |
16,013
+3,778
| +31% | +$36.4K |
|
2740
Adicet Bio
ACET
$78.5M
| $145K | ﹤0.01% |
+3,868
| New | +$160K |
|
2741
Sight Sciences
SGHT
$462M
| $145K | ﹤0.01% |
27,421
+2,487
| +10% | +$11.7K |
|
2742
Melco Resorts & Entertainment
MLCO
$2.14B
| $144K | ﹤0.01% |
20,025
| – | – |
|
2743
Lucid Motors
LCID
$2.52B
| $142K | ﹤0.01% |
4,980
+610
| +14% | +$19.5K |
|
|
GOOD
2744
Gladstone Commercial Corp
GOOD
$636M
| $140K | ﹤0.01% |
+10,127
| New | +$132K |
|
2745
Acumen Pharmaceuticals
ABOS
$178M
| $140K | ﹤0.01% |
34,604
+9,876
| +40% | +$37.2K |
|
2746
AXT Inc
AXTI
$5.12B
| $140K | ﹤0.01% |
30,439
+2,589
| +9% | +$8.79K |
|
2747
BRC Inc
BRCC
$211M
| $138K | ﹤0.01% |
+32,331
| New | +$134K |
|
|
TIGR
2748
UP Fintech Holding
TIGR
$818M
| $138K | ﹤0.01% |
40,135
| – | – |
|
2749
SiriusXM
SIRI
$9.56B
| $137K | ﹤0.01% |
3,543
+24
| +0.7% | +$1.14K |
|
|
NAPA
2750
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $137K | ﹤0.01% |
14,729
-1,394,214
| -99% | -$12.8M |
|
Similar funds
American Century Companies's Q1 2024 Portfolio in Review
As of Q1 2024, American Century Companies held 2,999 positions worth $159B, up 9.4% from $145B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
American Century Companies's Q1 2024 filing shows 122 new, 1,903 increased, 717 reduced and 75 closed positions. Its largest new stake was Bombardier Recreational Products: 736,453 shares worth $49.4M. The largest sale was Nike, an estimated $301M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q1 2024 buy was Bombardier Recreational Products: 736,453 shares worth $49.4M.
- American Century Companies added most to Meta Platforms (Facebook) in Q1 2024, an estimated $706M increase.
- American Century Companies's biggest Q1 2024 reduction was Nike, cutting an estimated $301M.
- American Century Companies fully exited Mobileye in Q1 2024, selling an estimated $74.8M.
- American Century Companies's ten largest holdings make up 24% of its $159B portfolio in Q1 2024.
- American Century Companies opened 122 new positions and closed 75 in Q1 2024.
- American Century Companies's portfolio value rose 9.4% quarter-over-quarter to $159B.
Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.